May/June

home / publications / evidence-based-diabetes-management / 2013-1-vol19-sp5

Clinical Outcomes Associated With Rates of Sulfonylurea Use Among Physicians

Katalin Bognar, PhD;Kelly Fee Bell, PharmD, MS Phr;Darius Lakdawalla, PhD;Anshu Shrestha, PhD;Julia Thornton Snider, PhD;Nina Thomas, MPH;Dana Goldman, PhD

ArticleEvidence-Based Diabetes Management

Gaming the System for Better Adherence

ArticleEvidence-Based Diabetes Management

Drugs Under Development for Cardiovascular Risk

Brice Labruzzo Mohundro, PharmD, BCACP

ArticleEvidence-Based Diabetes Management

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes

Michael E. Chernew, PhD;Rick McKellar, BS;Wade Aubry, MD;Roy Beck, MD, PhD;Joshua Benner, PharmD, ScD;Jan E. Berger, MD, MJ;A. Mark Fendrick, MD;Felicia Forma, BSc;Dana Goldman, PhD;Anne Peters, MD;Rebecca Killion, MA;Darius Lakdawalla, PhD;Douglas K. Owens, MD;Joe Stahl, MA

ArticleEvidence-Based Diabetes Management

BMI and Beyond: Identifing Obesity in Patients at Risk for Diabetes and Heart Disease

Marj P. Zimmerman, MS, BSPharm;Stanton R. Mehr

ArticleEvidence-Based Diabetes Management

Diabetes Apps: Impacting Patients' Lives Maximizing the Use of Mobile Applications for Patients with Diabetes Mellitus

Krisy-Ann Thornby, PharmD;Nicole Edquist, PharmD

ArticleEvidence-Based Diabetes Management

Innovations on the Horizon for the Treatment of Type 2 Diabetes An Interview With Javier Morales, MD

Stanton R. Mehr

ArticleEvidence-Based Diabetes Management

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions